Altaf Mohammed

发表

Chemopreventive effects of the p53-modulating agents CP-31398 and Prima-1 in tobacco carcinogen-induced lung tumorigenesis in A/J mice.

L. Kopelovich, S. Amin, D. Desai, 2013, Neoplasia.

Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers

R. Shoemaker, Altaf Mohammed, R. Lubet, 2019, Cancer Prevention Research.

Abstract 2820: Omeprazole alone, or in combination with Aspirin inhibits azoxymethane-induced colon adenoma progression to adenocarcinoma and carcinoma invasion in F344 rat model

V. Steele, C. Rao, J. Patlolla, 2015 .

Sea Cucumbers Metabolites as Potent Anti-Cancer Agents

C. Rao, Altaf Mohammed, N. Janakiram, 2015, Marine drugs.

Chemopreventive effects of PBI-Se, a selenium-containing analog of PBIT, on AOM-induced aberrant crypt foci in F344 rats.

S. Amin, D. Desai, C. Rao, 2013, Oncology reports.

Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma

V. Steele, C. Rao, Yuting Zhang, 2019, Cancer Prevention Research.

Multitargeted low-dose GLAD combination chemoprevention: a novel and promising approach to combat colon carcinogenesis.

V. Steele, C. Rao, Misty Brewer, 2013, Neoplasia.

Clinically Relevant Anti-Inflammatory Agents for Chemoprevention of Colorectal Cancer: New Perspectives

N. S. Yarla, C. Rao, Altaf Mohammed, 2018, International journal of molecular sciences.

Chemopreventive Efficacy of Raloxifene, Bexarotene, and Their Combination on the Progression of Chemically Induced Colon Adenomas to Adenocarcinomas in Rats

V. Steele, C. Rao, Yuting Zhang, 2013, Cancer Prevention Research.

Efficacy of EGFR Inhibitors and NSAIDs Against Basal Bladder Cancers in a Rat Model: Daily vs. Weekly Dosing, Combining EGFR Inhibitors with Naproxen, and Effects on RNA Expression

Jennifer T. Fox, Altaf Mohammed, R. Lubet, 2021, Bladder Cancer.

TP53 modulating agent, CP-31398 enhances antitumor effects of ODC inhibitor in mouse model of urinary bladder transitional cell carcinoma.

V. Steele, L. Kopelovich, C. Rao, 2015, American journal of cancer research.

Chemoprevention of Urothelial Cell Carcinoma Growth and Invasion by the Dual COX–LOX Inhibitor Licofelone in UPII-SV40T Transgenic Mice

V. Steele, L. Kopelovich, C. Rao, 2014, Cancer Prevention Research.

Inhibition of pancreatic intraepithelial neoplasia progression to carcinoma by nitric oxide-releasing aspirin in p48(Cre/+)-LSL-Kras(G12D/+) mice.

V. Steele, C. Rao, Altaf Mohammed, 2012, Neoplasia.

Chemopreventive effects of RXR-selective rexinoid bexarotene on intestinal neoplasia of Apc(Min/+) mice.

V. Steele, C. Rao, Lili Qian, 2012, Neoplasia.

Abstract 831: Chemopreventive effects of selective estrogen receptor modulator (SERM) raloxifene on intestinal neoplasia of APCMin/+ mice

V. Steele, C. Rao, Lili Qian, 2011 .

β-Ionone inhibits colonic aberrant crypt foci formation in rats, suppresses cell growth, and induces retinoid X receptor-α in human colon cancer cells

V. Steele, C. Rao, Altaf Mohammed, 2008, Molecular Cancer Therapeutics.

Loss of natural killer T cells promotes pancreatic cancer in LSL‐KrasG12D/+ mice

C. Rao, Altaf Mohammed, S. Lightfoot, 2017, Immunology.

Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP)

P. Brown, Altaf Mohammed, S. Sei, 2020, Cancer Prevention Research.

Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-Induced Colon Cancer in F344 Rat Model

V. Steele, C. Rao, Yuting Zhang, 2019, Cancer Prevention Research.

Targeting the Leukotriene Pathway for Colon Cancer Interception.

R. Shoemaker, Altaf Mohammed, 2022, Cancer prevention research.

p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice.

L. Kopelovich, C. Rao, Yuting Zhang, 2013, Neoplasia.

Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling.

V. Steele, C. Rao, Misty Brewer, 2013, Translational oncology.

Abstract 2268: Metformin prevents progression of pancreatic intraepithelial neoplasia to ductal adenocarcinoma by targeting cancer stem cells and mTOR signaling.

V. Steele, C. Rao, Misty Brewer, 2013 .

Abstract 2839: Licofelone, a novel dual COX-LOX inhibitor prevents progression of PanIN lesions to pancreatic carcinoma by targeting miRNAs and cancer stem cells in p48Cre/+-LSL-KrasG12D/+ transgenic mice

V. Steele, C. Rao, Altaf Mohammed, 2011 .

Biological effects and epidemiological consequences of arsenic exposure, and reagents that can ameliorate arsenic damage in vivo

C. Rao, Altaf Mohammed, M. Doescher, 2017, Oncotarget.

Prevention and treatment of cancers by immune modulating nutrients.

C. Rao, Altaf Mohammed, V. Madka, 2016, Molecular nutrition & food research.

Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting

P. Brown, R. Glynn, M. You, 2021, Journal of cancer prevention.

Targeting cholecystokinin‐2 receptor for pancreatic cancer chemoprevention

C. Rao, Altaf Mohammed, S. Lightfoot, 2019, Molecular carcinogenesis.

Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer

C. Rao, Altaf Mohammed, N. Janakiram, 2011, Cancer and Metastasis Reviews.

Simultaneous targeting of 5-LOX-COX and ODC block NNK-induced lung adenoma progression to adenocarcinoma in A/J mice.

V. Steele, L. Kopelovich, C. Rao, 2016, American journal of cancer research.

Naproxen inhibits spontaneous lung adenocarcinoma formation in KrasG12V mice

C. Rao, Altaf Mohammed, S. Lightfoot, 2021, Neoplasia.

Endogenous n-3 polyunsaturated fatty acids delay progression of pancreatic ductal adenocarcinoma in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+) mice.

C. Rao, Misty Brewer, Altaf Mohammed, 2012, Neoplasia.

Cancer Chemoprevention: Preclinical in vivo Alternate Dosing Strategies to Reduce Drug Toxicities.

Altaf Mohammed, M. S. Miller, Jennifer T Fox, 2019, Toxicological sciences : an official journal of the Society of Toxicology.

Pancreatic Cancer Chemoprevention: Challenges and Opportunities.

C. Rao, Altaf Mohammed, 2018, Current medicinal chemistry.

Chemopreventive Effects of an HDAC2-Selective Inhibitor on Rat Colon Carcinogenesis and APCmin/+ Mouse Intestinal Tumorigenesis

V. Steele, C. Rao, Lili Qian, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Chemopreventive Effects of an HDAC 2-Selective Inhibitor on Rat Colon Carcinogenesis and APCmin / 1 Mouse Intestinal Tumorigenesis s

V. Steele, C. Rao, Lili Qian, 2013 .

DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism.

M. Lerner, R. Postier, D. Brackett, 2011, Cancer research.

Molecular Targeted Intervention for Pancreatic Cancer

C. Rao, Altaf Mohammed, N. Janakiram, 2015, Cancers.

The Epidermal Growth Factor Receptor Inhibitor Gefitinib Prevents the Progression of Pancreatic Lesions to Carcinoma in a Conditional LSL-KrasG12D/+ Transgenic Mouse Model

Altaf Mohammed, Vernon E. Steele, Venkateshwar Madka, 2010, Cancer Prevention Research.

Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo

V. Steele, L. Kopelovich, C. Rao, 2015, Cancer Prevention Research.

Tumor-promoting/progressing role of additional chromosome instability in hepatic carcinogenesis in Sgo1 (Shugoshin 1) haploinsufficient mice.

C. Rao, Yuting Zhang, Altaf Mohammed, 2015, Carcinogenesis.

Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL‐KrasG12D/+ mice

V. Steele, C. Rao, Lili Qian, 2012, International journal of cancer.

Early and delayed intervention with Rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice

L. Kopelovich, C. Rao, J. Patlolla, 2015, Oncology reports.

Exosomal miRNAs as Novel Pharmacodynamic Biomarkers for Cancer Chemopreventive Agent Early Stage Treatments in Chemically Induced Mouse Model of Lung Squamous Cell Carcinoma

M. You, Liang Wang, Meijun Du, 2019, Cancers.

Adoptive transfer of regulatory T cells promotes intestinal tumorigenesis and is associated with decreased NK cells and IL‐22 binding protein

C. Rao, Misty Brewer, Altaf Mohammed, 2015, Molecular carcinogenesis.

Eflornithine (DFMO) Prevents Progression of Pancreatic Cancer by Modulating Ornithine Decarboxylase Signaling

V. Steele, C. Rao, J. Patlolla, 2014, Cancer Prevention Research.

Pancreatic cancer ductal cell of origin drives CD73-dependent generation of immunosuppressive adenosine

Zhongming Zhao, P. Brown, D. Bar-Sagi, 2021, bioRxiv.

Molecular Pathways: Mucins and Drug Delivery in Cancer

C. Rao, Altaf Mohammed, N. Janakiram, 2016, Clinical Cancer Research.

Systemic Chromosome Instability Resulted in Colonic Transcriptomic Changes in Metabolic, Proliferation, and Stem Cell Regulators in Sgo1-/+ Mice.

C. Rao, Yuting Zhang, Altaf Mohammed, 2016, Cancer research.

Chemoprevention of Colon and Small Intestinal Tumorigenesis in APCMin/+ Mice by Licofelone, a Novel Dual 5-LOX/COX Inhibitor: Potential Implications for Human Colon Cancer Prevention

V. Steele, C. Rao, Yuting Zhang, 2011, Cancer Prevention Research.

Small-Molecule Inhibition of GCNT3 Disrupts Mucin Biosynthesis and Malignant Cellular Behaviors in Pancreatic Cancer.

C. Rao, Yuting Zhang, Altaf Mohammed, 2016, Cancer research.

Prevention and Treatment of Pancreatic Cancer by Curcumin in Combination With Omega-3 Fatty Acids

C. Rao, J. Patlolla, Yuting Zhang, 2008, Nutrition and cancer.

Abstract 5074: Optimizing erlotinib plus sulindac dosing regimens in a preclinical model of FAP

P. Brown, Altaf Mohammed, S. Sei, 2019, Prevention, Early Detection, and Interception.

Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against Colon Cancer

V. Steele, C. Rao, Yuting Zhang, 2016, Scientific Reports.

Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma

V. Steele, C. Rao, Misty Brewer, 2015, Oncotarget.

(Z)-3,5,4'-Trimethoxystilbene Limits Hepatitis C and Cancer Pathophysiology by Blocking Microtubule Dynamics and Cell-Cycle Progression.

C. Rao, Altaf Mohammed, G. Waris, 2016, Cancer research.

Immune Modulation by Agents Used in the Prevention and Treatment of Colon and Pancreatic Cancers

C. Rao, Altaf Mohammed, N. Janakiram, 2015 .

Genetically engineered mouse models for hereditary cancer syndromes

R. Shoemaker, Altaf Mohammed, S. Sharan, 2023, Cancer science.

Lipoxygenase and Cyclooxygenase Pathways and Colorectal Cancer Prevention

C. Rao, Altaf Mohammed, N. Janakiram, 2012, Current Colorectal Cancer Reports.

Improved Innate Immune Responses by Frondanol A5, a Sea Cucumber Extract, Prevent Intestinal Tumorigenesis

V. Steele, C. Rao, Altaf Mohammed, 2015, Cancer Prevention Research.

New insights into pancreatic cancer stem cells.

C. Rao, Altaf Mohammed, 2015, World journal of stem cells.

Raloxifene and Antiestrogenic Gonadorelin Inhibits Intestinal Tumorigenesis by Modulating Immune Cells and Decreasing Stem-like Cells

C. Rao, Misty Brewer, Altaf Mohammed, 2014, Cancer Prevention Research.

Pharmacokinetics and tissue and tumor exposure of CP-31398, a p53-stabilizing agent, in rats

I. Kapetanovic, L. Kopelovich, C. Rao, 2012, Cancer Chemotherapy and Pharmacology.

Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer

V. Steele, C. Rao, Yuting Zhang, 2017, Oncotarget.

TargetingmTORandp53Signaling InhibitsMuscle Invasive Bladder Cancer In Vivo

V. Steele, L. Kopelovich, C. Rao, 2015 .

Chemopreventive Effects of Frondanol A5, a Cucumaria frondosa Extract, against Rat Colon Carcinogenesis and Inhibition of Human Colon Cancer Cell Growth

V. Steele, C. Rao, Yuting Zhang, 2010, Cancer Prevention Research.

Combination of naproxen and a chemically‐stable eicosapentaenoic acid analog provide additive tumor protection in Pirc rats

Altaf Mohammed, D. Rosenberg, S. Sei, 2023, International journal of cancer.

Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer

P. Brown, Yun Zhang, Altaf Mohammed, 2022, Cancer prevention research.

Proton Pump Inhibitor Omeprazole Suppresses Carcinogen-induced Colonic Adenoma Progression to Adenocarcinoma in F344 Rat

V. Steele, C. Rao, Yuting Zhang, 2021, Cancer Prevention Research.

CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer

P. Brown, D. Bar-Sagi, Altaf Mohammed, 2023, Cancer research.

Chemoprevention of Colon and Small Intestinal Tumorigenesis in APCmin/+ Mice By SHetA2 (NSC721689) without Toxicity

Yuhong Wang, C. Rao, Yuting Zhang, 2013, Cancer Prevention Research.

Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression

V. Steele, C. Rao, J. Patlolla, 2015, Oncotarget.

Mass profiling of serum to distinguish mice with pancreatic cancer induced by a transgenic Kras mutation

J. Hanas, J. Hocker, C. Rao, 2013, International journal of cancer.

Abstract 2927: Gefitinib, an EGFR inhibitor, prevents progression of PanINs to pancreatic carcinoma in a preclinical conditionalLSL-K-rasG12Dtransgenic mice model

V. Steele, C. Rao, Lili Qian, 2010 .

Synthesis and in vivo evaluation of N-ethylamino-2-oxo-1,2-dihydro-quinoline-3-carboxamide for inhibition of intestinal tumorigenesis in APC(Min/+) mice.

C. Rao, Altaf Mohammed, G. Pathuri, 2014, Bioorganic & Medicinal Chemistry Letters.

Abstract 4983: Intermittent dosing regimens of naproxen and aspirin inhibit azoxymethane-induced rat colon adenoma progression to adenocarcinoma and carcinoma invasion

V. Steele, C. Rao, Yuting Zhang, 2018, Prevention Research.

Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats

C. Rao, J. Patlolla, Yuting Zhang, 2023, Cancers.

Molecular Carcinogenesis

Ashutosh Kumar Singh, C. Rao, Altaf Mohammed, 2019 .

Evaluation of Power Conservation Algorithms in Industrial Wireless Sensor Networks

Naveen Garlapati, Altaf Ahmed Mohammed, Altaf Mohammed, 2012 .

Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report

R. Shoemaker, E. Jaffee, J. Schlom, 2022 .

Cancer Immunoprevention: Challenges and Potential Opportunities for Use of Immune Checkpoint Inhibitors

R. Shoemaker, Altaf Mohammed, S. Sei, 2020, Cancer Prevention Research.

DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism.

M. Lerner, R. Postier, D. Brackett, 2011, Cancer Research.

Abstract 821: miRNA profiling and target identification during normal pancreata transformation to PanINs to pancreatic ductal cancer progression in p48Cre/+-LSL-KrasG12D/+ mice: Implication for human pancreatic cancer chemoprevention and treatment

V. Steele, C. Rao, Lili Qian, 2011 .

Endogenous n-3 Polyunsaturated Fatty Acids Delay Progression of Pancreatic Ductal Adenocarcinoma

D. A. McGee, C. Rao, Altaf Mohammed, 2012 .

Prevention and treatment of cancers by immune modulating nutrients.

C. Rao, Altaf Mohammed, N. Janakiram, 2016, Molecular nutrition & food research.

Small-Molecule Inhibition of GCNT3 Disrupts Mucin Biosynthesis and Malignant Cellular Behaviors in Pancreatic Cancer.

C. Rao, Yuting Zhang, Altaf Mohammed, 2016, Cancer Research.

Mass profiling of serum to distinguish mice with pancreatic cancer induced by a transgenic Kras mutation

J. Hanas, J. Hocker, C. Rao, 2013, International journal of cancer.

Early detection and prevention of pancreatic cancer: use of genetically engineered mouse models and advanced imaging technologies.

C. Rao, Altaf Mohammed, S. Lightfoot, 2012, Current medicinal chemistry.

Chemopreventive Effects of Frondanol A5, a Cucumaria frondosa Extract, against Rat Colon Carcinogenesis and Inhibition of Human Colon Cancer Cell Growth

V. Steele, C. Rao, Yuting Zhang, 2010, Cancer Prevention Research.

Systemic Chromosome Instability Resulted in Colonic Transcriptomic Changes in Metabolic, Proliferation, and Stem Cell Regulators in Sgo1-/+ Mice.

C. Rao, Yuting Zhang, Altaf Mohammed, 2016, Cancer research.

Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report

R. Shoemaker, E. Jaffee, J. Schlom, 2021, Journal of cancer prevention.

Chemopreventive Effects of an HDAC2-Selective Inhibitor on Rat Colon Carcinogenesis and APCmin/+ Mouse Intestinal Tumorigenesis

V. Steele, C. Rao, Lili Qian, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Abstract B42: Lack of chemopreventive effects of metformin in azoxymethane-induced rat colon carcinogenesis

V. Steele, C. Rao, Lili Qian, 2011 .